More Bevacizumab Shots for AMD May Up Risk of Glaucoma

Source: MedPage Today

Friday, March 17, 2017 | Medical Studies , Retina


Patients who receive repeated eye injections of the drug bevacizumab for age-related macular degeneration have an increased risk of subsequent glaucoma surgery, suggested results from a nested case-control study.

Open in New Window

Comments

You must be logged in to leave a comment.